Patents Assigned to Screenpoint Medical B.V.
  • Publication number: 20240127959
    Abstract: The invention relates to an apparatus for determining a temporal breast cancer risk (27). This risk is indicative of detecting cancer in a breast within a predetermined time interval after a negative breast cancer detection result that has been obtained by carrying out a breast cancer detection procedure defined by a breast cancer detection parameter. The temporal breast cancer risk (27) is determined based on a) a probability parameter (25) being indicative of a probability of having breast cancer and b) a density parameter (26) being indicative of a density-related property of breast tissue of a breast, wherein the probability parameter (25) and the density parameter (26) have been determined based on a breast image data set (24) of the woman by using an artificial intelligence. The determined risk can be used, for instance, for deciding whether a supplemental examination should be performed immediately or for defining a screening interval.
    Type: Application
    Filed: March 1, 2022
    Publication date: April 18, 2024
    Applicant: Screenpoint Medical B.V.
    Inventors: Nico Karssemeijer, Mehmet Dalmis, Alejandro Rodriguez, Natasja Jansen, Michiel Kallenberg, Jeroen Schouwenberg